Trials / Completed
CompletedNCT00288587
Extracorporeal Ultrafiltration (UF) vs. Usual and Customary Care for Patients With Severe Heart Failure (HF)
CP0007: Extracorporeal Ultrafiltration (UF) vs. Usual and Customary Care for Patients With Severe Heart Failure (HF)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- NxStage Medical · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the ability of Ultrafiltration to influence the rate of hemodynamic improvement, as measured by the decline in the pulmonary artery occlusion pressure, in patients with NYHA class III/IV Heart Failure.
Detailed description
This study will be preformed in a specialized heart failure unit at the Cleveland Clinic Foundation (CCF) and will include both the UF-treated group and a control group receiving usual and customary care. Patients will be stratified according to renal function at the time of admission. Therapies will be guided by specific hemodynamic criteria routinely used at the study institution.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | IV loop diuretic | Use of conventional diuretic therapy upon hospital admission for treatment of decompensated heart failure. |
| DEVICE | NxStage System One | Patients treated with Extracorporeal Ultrafiltration upon hospital admission for treatment of decompensated heart failure. |
Timeline
- Start date
- 2003-10-01
- Primary completion
- 2008-09-01
- Completion
- 2009-01-01
- First posted
- 2006-02-08
- Last updated
- 2012-06-19
- Results posted
- 2012-06-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00288587. Inclusion in this directory is not an endorsement.